TOXTA 100 UNITS

  Toxta 100U is a highly purified Botulinum Toxin Type A injectable developed for the temporary improvement of dynamic facial wrinkles caused by repetitive muscle movement. Manufactured using advanced purification technology, Toxta 100U provides precise muscle relaxation for smoother, younger-looking skin while maintaining natural facial expressions when administered by a qualified medical professional. It is also used in a variety of therapeutic applications involving muscle hyperactivity.

Indications

Toxta 100U is commonly used for:

• Glabellar (frown) lines

• Forehead wrinkles

• Crow's feet (lateral canthal lines)

• Bunny lines

• Chin dimpling

• Downturned corners of the mouth

• Platysmal neck bands

• Brow lifting

• Jawline slimming (masseter hypertrophy)

• Treatment of excessive sweating (hyperhidrosis), where appropriate

• Other therapeutic or aesthetic indications as determined by a qualified healthcare professional

Active Ingredient

• Clostridium botulinum toxin type A: 100 Units

• Human Serum Albumin

• Sodium Chloride

Key Benefits

• Smooths moderate to severe dynamic facial wrinkles

• Produces natural-looking facial rejuvenation

• High purity formulation with consistent clinical performance

• Precise muscle relaxation while preserving natural facial expression

• Quick, minimally invasive treatment

• Minimal downtime with rapid return to daily activities

• Results typically become visible within 3–7 days, with full effect in approximately 10–14 days

• Effects generally last 3–6 months, depending on the treatment area and individual response

Treatment Areas

Suitable for treatment of:

• Forehead

• Glabella (between the eyebrows)

• Crow's feet

• Nose (bunny lines)

• Chin

• Jawline (masseter muscles)

• Neck

• Underarms (for hyperhidrosis)

• Other approved facial muscles as clinically indicated

Administration

Toxta 100U is supplied as a sterile lyophilized powder and must be reconstituted with preservative-free sterile sodium chloride solution before injection. It should only be administered by qualified healthcare professionals experienced in botulinum toxin treatments.

Onset and Duration

• Initial onset: Typically 3–7 days after treatment

• Maximum effect: Approximately 10–14 days

• Duration: Approximately 3–6 months, depending on the treated area, dosage, injection technique, and individual metabolism

Packaging

• 1 vial containing 100 Units of Botulinum Toxin Type A

• Single-use vial

• Package insert

Origin

Country of Manufacture: South Korea

Storage

• Store unopened vials refrigerated at 2°C–8°C.

• Do not freeze unless specified by the manufacturer.

• Protect from direct light.

• Use the reconstituted solution according to the manufacturer's storage recommendations.

Precautions

• For professional use only by licensed healthcare practitioners.

• Do not use in patients with known hypersensitivity to botulinum toxin or any formulation component.

• Contraindicated in the presence of infection at the intended injection site.

• Use with caution in patients with neuromuscular disorders.

• Temporary injection-site redness, swelling, bruising, headache, or localized muscle weakness may occur.

• Avoid strenuous exercise, rubbing the treated area, or lying flat for several hours after treatment, as advised by the treating practitioner.

Product Specifications